Corcept Therapeutics director completes $3.3M share purchases amid earnings miss and legal action
Corcept Therapeutics director Baker G Leonard Jr. executed two purchases of the company's common stock on March 17, 2026, totaling $3.3 million. The trades added 100,000 shares to his direct holdings and leave him with over 1.1 million directly held shares, alongside substantial indirect holdings through a limited partnership and a trust. The stock…